Since PRMT5 acts as the master regulator of sDMA and governs multi‐processes depending on the substrates it methylates, the influence of PRMT5 in tumor progression might be dissimilar in different spatiotemporal situations. The gene discussed is PRMT5; the disease is neoplasm.